109 related articles for article (PubMed ID: 18538613)
21. Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing.
Lewis LA; Shafer WM; Dutta Ray T; Ram S; Rice PA
Infect Immun; 2013 Jan; 81(1):33-42. PubMed ID: 23071134
[TBL] [Abstract][Full Text] [Related]
22. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries.
Sakota V; Fry AM; Lietman TM; Facklam RR; Li Z; Beall B
J Clin Microbiol; 2006 Jun; 44(6):2160-6. PubMed ID: 16757615
[TBL] [Abstract][Full Text] [Related]
23. Comparative epidemiology of Streptococcus pyogenes emm-types causing invasive and noninvasive infections in French children by use of high-resolution melting-polymerase chain reaction.
d'Humières C; Bidet P; Levy C; Béchet S; Bonacorsi S; Bingen E; Cohen R
Pediatr Infect Dis J; 2015 Jun; 34(6):557-61. PubMed ID: 25973933
[TBL] [Abstract][Full Text] [Related]
24. Nontypeable
Thofte O; Bettoni S; Su YC; Thegerström J; Jonsson S; Mattsson E; Sandblad L; Martí S; Garmendia J; Blom AM; Riesbeck K
J Immunol; 2021 Sep; 207(6):1566-1577. PubMed ID: 34433620
[TBL] [Abstract][Full Text] [Related]
25. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
[TBL] [Abstract][Full Text] [Related]
26. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion.
Agarwal V; Hammerschmidt S; Malm S; Bergmann S; Riesbeck K; Blom AM
J Immunol; 2012 Oct; 189(7):3575-84. PubMed ID: 22925928
[TBL] [Abstract][Full Text] [Related]
27. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.
Malm S; Jusko M; Eick S; Potempa J; Riesbeck K; Blom AM
PLoS One; 2012; 7(4):e34852. PubMed ID: 22514678
[TBL] [Abstract][Full Text] [Related]
28. [Beta-hemolytic streptococci in tonsil hypertrophy and recurrent tonsillitis].
Ramírez A; Peidrola D; López A; Martínez MD; Ros MJ; Corral JL; Arteaga E
Enferm Infecc Microbiol Clin; 1997; 15(6):315-8. PubMed ID: 9376403
[TBL] [Abstract][Full Text] [Related]
29. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion.
Dieudonné-Vatran A; Krentz S; Blom AM; Meri S; Henriques-Normark B; Riesbeck K; Albiger B
J Immunol; 2009 Jun; 182(12):7865-77. PubMed ID: 19494311
[TBL] [Abstract][Full Text] [Related]
30. Characterization of group A streptococci isolated in Kuala Lumpur, Malaysia.
Jamal F; Pit S; Johnson DR; Kaplan EL
J Trop Med Hyg; 1995 Oct; 98(5):343-6. PubMed ID: 7563264
[TBL] [Abstract][Full Text] [Related]
31. Septicaemia caused by phenotypic variants of group A streptococci.
Geslin P; Kriz-Kuzemenska P; Frémaux A; Havlickova H; Dublanchet A; Bouvet A
Res Microbiol; 1996 May; 147(4):273-7. PubMed ID: 8763614
[TBL] [Abstract][Full Text] [Related]
32. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP.
Castiblanco-Valencia MM; Fraga TR; Silva LB; Monaris D; Abreu PA; Strobel S; Józsi M; Isaac L; Barbosa AS
J Infect Dis; 2012 Mar; 205(6):995-1004. PubMed ID: 22291192
[TBL] [Abstract][Full Text] [Related]
33. High burden of invasive beta-haemolytic streptococcal infections in Fiji.
Steer AC; Jenney AJ; Oppedisano F; Batzloff MR; Hartas J; Passmore J; Russell FM; Kado JH; Carapetis JR
Epidemiol Infect; 2008 May; 136(5):621-7. PubMed ID: 17631691
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of regulators of complement activation by Streptococcus pyogenes serotype M1.
Pandiripally V; Gregory E; Cue D
Infect Immun; 2002 Nov; 70(11):6206-14. PubMed ID: 12379699
[TBL] [Abstract][Full Text] [Related]
35. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
Shulman ST; Stollerman G; Beall B; Dale JB; Tanz RR
Clin Infect Dis; 2006 Feb; 42(4):441-7. PubMed ID: 16421785
[TBL] [Abstract][Full Text] [Related]
36. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
Shulman ST; Tanz RR; Kabat W; Kabat K; Cederlund E; Patel D; Li Z; Sakota V; Dale JB; Beall B;
Clin Infect Dis; 2004 Aug; 39(3):325-32. PubMed ID: 15306998
[TBL] [Abstract][Full Text] [Related]
37. Enolase From
Dasari P; Koleci N; Shopova IA; Wartenberg D; Beyersdorf N; Dietrich S; Sahagún-Ruiz A; Figge MT; Skerka C; Brakhage AA; Zipfel PF
Front Immunol; 2019; 10():2573. PubMed ID: 31824478
[TBL] [Abstract][Full Text] [Related]
38. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
39. A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP.
Johnsson E; Thern A; Dahlbäck B; Hedén LO; Wikström M; Lindahl G
J Immunol; 1996 Oct; 157(7):3021-9. PubMed ID: 8816411
[TBL] [Abstract][Full Text] [Related]
40. Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein.
Vogl G; Lesiak I; Jensen DB; Perkhofer S; Eck R; Speth C; Lass-Flörl C; Zipfel PF; Blom AM; Dierich MP; Würzner R
Mol Immunol; 2008 Mar; 45(5):1485-93. PubMed ID: 17915330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
